Success Metrics

Completion Rate
0%(0/1)
Active Trials
2(67%)
Terminated
1(33%)

Phase Distribution

Ph not_applicable
3
100%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution3 total trials
N/ANon-phased studies
3(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

0.0%

0 of 1 finished

Non-Completion Rate

100.0%

1 ended early

Currently Active

2

trials recruiting

Total Trials

3

all time

Status Distribution
Active(2)
Terminated(1)

Detailed Status

Recruiting1
Active, not recruiting1
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
3
Active
2
Success Rate
0.0%
Most Advanced
N/A

Trials by Phase

N/A3 (100.0%)

Trials by Status

recruiting133%
active_not_recruiting133%
terminated133%

Recent Activity

2 active trials
Showing 3 of 3
terminatednot_applicable

SafeHeal Colovac Colorectal Anastomosis Protection Device Evaluation (SAFE-2) Pivotal Study

NCT05010850
recruitingnot_applicable

Safety and Effectiveness Evaluation of the COLO-BT as an Alternative Treatment to the Ileostomy

NCT05826743
active_not_recruitingnot_applicable

SafeHeal Anastomosis Feasibility Evaluation (SAFE)-2023 Study

NCT06540807

Clinical Trials (3)

Showing 3 of 3 trials
NCT05010850Not Applicable

SafeHeal Colovac Colorectal Anastomosis Protection Device Evaluation (SAFE-2) Pivotal Study

Terminated
NCT05826743Not Applicable

Safety and Effectiveness Evaluation of the COLO-BT as an Alternative Treatment to the Ileostomy

Recruiting
NCT06540807Not Applicable

SafeHeal Anastomosis Feasibility Evaluation (SAFE)-2023 Study

Active Not Recruiting

All 3 trials loaded

Drug Details

Intervention Type
PROCEDURE
Total Trials
3